HEOR/RWE Scientist with Clinical Research Leadership

Wen Hsin Chen (Minnie)

********@***.*** • 979-***-****

Work Experience

HEOR/RWE Scientist (Fellow) at AbbVie Medical Affair /Value & Evidence July 2024 – June 2026

• Partnered with strategy, clinical, KOL and external stakeholders to develop RWE projects across SCLC, CLL, AML and MM, supporting Payor Value Desk and HCP education material.

• Led study design and analytic planning, synthesized insights for stakeholder alignment, and delivered RWE outputs reinforcing AbbVie’s product value story.

• Led 7 protocol-based RWE analyses at AbbVie, supporting 5 planned abstracts and 1 planned manuscript.

• Led 2 diabetes protocol plans development, publication process and result in 3 ISPOR abstracts and manuscript Research Assistant at Texas A&M University Sep 2021 – June 2024

• Partnered with clinical, academic, and community health worker teams to design a patient engagement plan to refine clinical engagement strategies, and present visualized performance reports in regular meeting.

• Led the design, analysis, and publication processes for three research studies, resulting in three first-author peer- reviewed publications and support Bayer’s chronic kidney disease RWE project. Business Developer at aertherAI June 2020 – June 2021

• Collaborated with pathologists and hematologists to deliver an AI-enabled digital pathology and hematology visualization system, supporting clinical decision-making at Taiwan’s largest medical center.

• Managed five digital pathology projects across five medical centers and introduced a digital pathology system to transform hematology specialist training through the Taiwan Society of Hematology. Selected Research Project

Small Cell Lung Cancer Healthcare Resource Utilization projects

• Partnered with strategy lead and clinical teams to design study protocols, conduct analyses, oversee publication submissions, and deliver findings to external stakeholders for Payor Value Desk. Chronic lymphocytic leukemia Health Outcome projects

• Led real-world effectiveness analyses of venetoclax in CLL in partnership with strategy and RWE leadership and consulting groups to support FDA label expansion and HCP education initiatives. Acute Myeloid Leukemia Health Outcome and HCRU projects

• Led HCRU and real-world effectiveness analyses among AML populations, partnering with Strategy and RWE leadership, CROs, and external consultants to inform market access Strategy. Education

Texas A&M University, College Station, Texas Sep 2021 – Jun 2024 Master of Science in Health Policy and Management (MSPH) University College London, London, United Kingdom Sep 2019 – Jun 2020 Master of Science (MSc) in Population Health, Upper Second-Class Honour Taipei Medical University, Taipei, Taiwan Sep 2014 – Jun 2017 Bachelor of Science (BSc) in Science of Nursing

Skills

• Skills: Stata, SAS, R, IHD, Data Visualization, Claims data, EHR data, Registry data, eCFR

• Domain Knowledge: Chronic Lymphocytic Leukemia, Small Cell Lung Cancer, Type II Diabetes, Acute Myeloid Leukemia, Multiple Myeloma

Selected Publications

• Chen, W. H., Bloom, R. D., Brandford, A., Han, G., Horel, S., Sanchez, M., McKnight, J., & Bolin, J. L. (2025). Persistent poverty, rural location, and racial segregation are factors in colorectal cancer screening in low-income and uninsured populations. Journal of Advanced Practitioner in Oncology

• Chen, W. H., Ohsfeldt, R., Côté, M., Shipp, E., Sanchez, M., Brandford, A., & Bolin, J. N. (2025). Examining the cost- effectiveness of introducing patient navigation services for colorectal cancer screening among a low-income and uninsured population. Health Services Insights

• Chen, W. H., Brandford, A., Bloom, R., Han, G., Horel, S., Sanchez, M., Lichorad, A., & Bolin, J. (2024). Factors associated with abnormal mammogram results among low-income uninsured populations in medically underserved and rural Texas regions. Women's Health Reports

Contact this candidate